LyndsayJeanWillmottMD

PubMed

• 1 citations
  Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly di...
  Sandro Pignata, Michael Bookman, Jalid Sehouli, Austin Miller, Richard T Penson, Cagatay Taskiran, Charles Anderson, Sakari Hietanen, Tashanna Myers, Radoslaw Madry, L...> ;Gynecologic Oncology. 2023 Oct 1
• Factors Associated with Inpatient Narcotic Medication Usage after Robotic-assisted Laparoscopy.
  Chelsea Stewart, Andrea Moreno, Elise Vo, Bikash Bhattarai, John Farley, Lyndsay Willmott, Bradley J Monk, Dana M Chase> ;Journal of Minimally Invasive Gynecology. 2023 Nov 1
• Robotic-assisted gynecologic surgery in an older population: A comparison study.
  Madison S Moore, Elise H Vo, Bikash Bhattarai, John H Farley, Bradley J Monk, Lyndsay J Willmott, Dana M Chase> ;Journal of Geriatric Oncology. 2023 Jul 1
• 1 citations
  Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer.
  Paweł Łaniewski, Haiyan Cui, Nichole D Mahnert, Jamal Mourad, Matthew P Borst, Lyndsay Willmott, Dana M Chase, Denise J Roe, Melissa M Herbst-Kralovetz> ;Biomarker Research. 2022 Dec 2
• 6 citations
  Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial.
  Dana M Chase, Margarita Romeo Marín, Floor Backes, Sileny Han, Whitney Graybill, Mansoor Raza Mirza, Bhavana Pothuri, Giorgia Mangili, David M O'Malley, Dominique Bert...> ;Gynecologic Oncology. 2022 Sep 1
• 153 citations
  Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT...
  Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli, Austin Miller, Charles K. Anderson, Giovanni Scambia, Tashanna Myers, Cagatay Taskiran, Katina Robison, Johanna M...> ;Journal of Clinical Oncology. 2021 Apr 23
• 8 citations
  Safety and Efficacy of Salvage Nano-Particle Albumin Bound Paclitaxel in Recurrent Cervical Cancer: A Feasibility Study
  Lindsey E. Minion, Dana M. Chase, John H. Farley, L. Willmott, Bradley J. Monk> ;Gynecologic Oncology Research and Practice. 2016 Apr 14
• 1 citations
  Biologics in cervical cancer therapy.
  Lyndsay J. Willmott, Daniele A. Sumner, Bradley J. Monk> ;Journal of the National Comprehensive Cancer Network. 2010 Dec 1
• 80 citations
  Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture
  Valerie Trapp, Basmina Parmakhtiar, Vartan Papazian, Lyndsay J. Willmott, John P. Fruehauf> ;Angiogenesis. 2010 Oct 7
• 36 citations
  Targeted Therapy in Ovarian Cancer
  Lyndsay J. Willmott, John P. Fruehauf> ;Journal of Oncology. 2010 Jan 14
• 49 citations
  Anti-angiogenesis agents in metastatic or recurrent cervical cancer
  Bradley J. Monk, Lyndsay J. Willmott, Daniele A. Sumner> ;Gynecologic Oncology. 2010 Feb 1
• 37 citations
  Cervical cancer therapy: current, future and anti- angiogensis targeted treatment
  Lyndsay J. Willmott, Bradley J. Monk> ;Expert Review of Anticancer Therapy. 2009 Jul 1
• 12 citations
  Catalysis of strand annealing by replication protein A derives from its strand melting properties.
  Jeremy D. Bartos, Lyndsay J. Willmott, Sara K. Binz, Marc S. Wold, Robert A. Bambara> ;The Journal of Biological Chemistry. 2008 Aug 1
• 22 citations
  Genomic heterogeneity and instability in colorectal cancer: spectral karyotyping, glutathione transferase-Ml and ras.
  Jeremy D. Bartos, Daniel L. Stoler, Sei-Ichi Matsui, Helen Swede, Lyndsay J. Willmott, Sheila N.J. Sait, Nicholas J. Petrelli, Garth R. Anderson> ;Mutation Research. 2004 Dec 21
• Join now to see all